Assessment
Questionnaire
See what questions
a doctor would ask.
Rosiglitazone: An orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic activity. Rosiglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-gamma), a ligand-activated transcription factor, thereby inducing cell differentiation and inhibiting cell growth and angiogenesis. This agent also modulates the transcription of insulin-responsive genes, inhibits macrophage and monocyte activation, and stimulates adipocyte differentiation.(NCI04)
Source: Diseases Database
Rosiglitazone: peroxisome proliferator activated receptor agonist; reduces lipid availability; improves insulin action and glucoregulation.
Source: CRISP
These medical condition or symptom topics may be relevant to medical information for Rosiglitazone:
Source - CRISP
Source: CRISP
Source: Diseases Database
Search to find out more about Rosiglitazone:
|
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2011 Health Grades Inc. All rights reserved. Last Update: 7 May, 2013 (0:58)